10159 related articles for article (PubMed ID: 12725332)
1. Correlation of gangliosides GM2 and GM3 with metastatic potential to lungs of mouse B16 melanoma.
Saha S; Mohanty KC
J Exp Clin Cancer Res; 2003 Mar; 22(1):125-34. PubMed ID: 12725332
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of metastatic potential of mouse B16-melanoma cells to lung after treatment with gangliosides of B-16-melanoma cells of higher metastatic potential to lung.
Saha S; Mohanty KC
Indian J Exp Biol; 2003 Nov; 41(11):1253-8. PubMed ID: 15332492
[TBL] [Abstract][Full Text] [Related]
3. Secretion of metastasis related gangliosides by mouse B16-melanoma in circulation in vivo and in culture media in vitro.
Saha S; Mohanty KC
Indian J Exp Biol; 2004 Oct; 42(10):976-80. PubMed ID: 15511000
[TBL] [Abstract][Full Text] [Related]
4. Gangliosides enhance migration of mouse B16-melanoma cells through artificial basement membrane alone or in presence of laminin or fibronectin.
Saha S; Mohanty KC; Mallick P
Indian J Exp Biol; 2005 Dec; 43(12):1130-8. PubMed ID: 16359123
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of sialidase activity and G(M3) content in B16 melanoma variants with different metastatic potential.
Sawada M; Moriya S; Shineha R; Satomi S; Miyagi T
Acta Biochim Pol; 1998; 45(2):343-9. PubMed ID: 9821865
[TBL] [Abstract][Full Text] [Related]
6. Cell surface accessibility of individual gangliosides in malignant melanoma cells to antibodies is influenced by the total ganglioside composition of the cells.
Lloyd KO; Gordon CM; Thampoe IJ; DiBenedetto C
Cancer Res; 1992 Sep; 52(18):4948-53. PubMed ID: 1516051
[TBL] [Abstract][Full Text] [Related]
7. Generation of phenotypic diversity in the B16 mouse melanoma relative to spontaneous metastasis.
Stackpole CW
Cancer Res; 1983 Jul; 43(7):3057-65. PubMed ID: 6850615
[TBL] [Abstract][Full Text] [Related]
8. Alteration of tumor phenotypes of B16 melanoma after genetic remodeling of the ganglioside profile.
Tsurifune T; Ito T; Li XJ; Yamashiro S; Okada M; Kanematsu T; Shiku H; Furukawa K
Int J Oncol; 2000 Jul; 17(1):159-65. PubMed ID: 10853034
[TBL] [Abstract][Full Text] [Related]
9. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
[TBL] [Abstract][Full Text] [Related]
10. Glycosphingolipid expression on murine L1-fibrosarcoma cells: analysis of clonal in vivo and in vitro selected sublines with different lung colonisation potential.
Hanisch FG; Sölter J; Jansen V; Lochner A; Peter-Katalinic J; Uhlenbruck G
Br J Cancer; 1990 Jun; 61(6):813-20. PubMed ID: 2372482
[TBL] [Abstract][Full Text] [Related]
11. Differential cell- and immuno-biological properties of murine B16-F1 and F10 melanomas: oncogene c-fos expression, sensitivity to LAK cells and/or IL-2, and components of gangliosides.
Nakayama J; Urabe K; Tsuchida T; Urabe A; Terao H; Taniguchi S; Hori Y
J Dermatol; 1995 Aug; 22(8):549-59. PubMed ID: 7560451
[TBL] [Abstract][Full Text] [Related]
12. Glycosylation pathways in the biosynthesis of gangliosides in melanoma and neuroblastoma cells: relative glycosyltransferase levels determine ganglioside patterns.
Ruan S; Lloyd KO
Cancer Res; 1992 Oct; 52(20):5725-31. PubMed ID: 1394196
[TBL] [Abstract][Full Text] [Related]
13. Five new epitope-defined monoclonal antibodies reactive with GM2 and human glioma and medulloblastoma cell lines.
Vrionis FD; Wikstrand CJ; Fredman P; Månsson JE; Svennerholm L; Bigner DD
Cancer Res; 1989 Dec; 49(23):6645-51. PubMed ID: 2479468
[TBL] [Abstract][Full Text] [Related]
14. Ganglioside GM2 levels in human melanoma cells: inverse correlation with lysosomal beta-hexosaminidase A activity.
Hoon DS; Kaback MM; Lim-Steele J; Tsuchida T; Morton DL; Irie RF
Biochem Int; 1992 Jul; 27(2):343-52. PubMed ID: 1386984
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of highly metastatic FBJ-LL cell migration by ganglioside GD1a highly expressed in poorly metastatic FBJ-S1 cells.
Hyuga S; Yamagata S; Tai T; Yamagata T
Biochem Biophys Res Commun; 1997 Feb; 231(2):340-3. PubMed ID: 9070274
[TBL] [Abstract][Full Text] [Related]
16. Effect of lactose derivatives on metastatic potential of B16 melanoma cells.
Oguchi H; Toyokuni T; Dean B; Ito H; Otsuji E; Jones VL; Sadozai KK; Hakomori S
Cancer Commun; 1990; 2(9):311-6. PubMed ID: 2206779
[TBL] [Abstract][Full Text] [Related]
17. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.
Wang BS; McLoughlin GA; Richie JP; Mannick JA
Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511
[TBL] [Abstract][Full Text] [Related]
18. Metastatic potential and multidrug resistance correlation in the B16 melanoma system.
Staroselsky AN; Mahlin T; Savion N; Klein O; Nordenberg J; Donin N; Michowitz M; Leibovici J
J Exp Ther Oncol; 1996 Jul; 1(4):251-9. PubMed ID: 9414412
[TBL] [Abstract][Full Text] [Related]
19. Mice deficient in Neu4 sialidase exhibit abnormal ganglioside catabolism and lysosomal storage.
Seyrantepe V; Canuel M; Carpentier S; Landry K; Durand S; Liang F; Zeng J; Caqueret A; Gravel RA; Marchesini S; Zwingmann C; Michaud J; Morales CR; Levade T; Pshezhetsky AV
Hum Mol Genet; 2008 Jun; 17(11):1556-68. PubMed ID: 18270209
[TBL] [Abstract][Full Text] [Related]
20. The role of intratumor environment in determining spontaneous metastatic activity of a B16 melanoma clone.
Alterman AL; Fornabaio DM; Kim YS; Stackpole CW
Invasion Metastasis; 1989; 9(4):242-53. PubMed ID: 2737843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
